Funder
The Canadian Cohort Obstructive Lung Disease (CanCOLD)
Canadian Respiratory Research Network
AstraZeneca Canada
Boehringer Ingelheim Canada Ltd.
GlaxoSmithKline Canada Ltd.
Novartis
CIHR/Rx&D Collaborative Research Program Operating Grants
Respiratory Health Network of the FRSQ
Almirall
Merck
Nycomed
Pfizer Canada Ltd.
Theratechnologies
CIHR
AbbVie
Canadian Institutes of Health Research
GlaxoSmithKline
Grifols
Aerocrine
Subject
Pulmonary and Respiratory Medicine
Reference39 articles.
1. World Health Organization, WHO | Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach, World Health Organization, Geneva, Switzerland. http://www.who.int/gard/publications/GARD_Manual/en. Accessed 12th January 2017.
2. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease;Soler-Cataluna;Thorax,2005
3. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system;Mittmann;Respir. Med.,2008
4. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles;Yohannes;Int. J. Geriatr. Psychiatr.,2010
5. The association of cigarette smoking with depression and anxiety: a systematic review;Fluharty;Nicotine Tob. Res.,2017
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献